Alok Kulshreshtha

Title: Alok Kulshreshtha: Innovator in Pharmaceutical Formulations

Introduction

Alok Kulshreshtha is a notable inventor based in Grapevine, TX (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable protein solutions. With a total of 2 patents to his name, his work focuses on enhancing the delivery of therapeutic antibodies.

Latest Patents

Kulshreshtha's latest patents include a formulation for a stable protein solution containing a high concentration of an anti-VEGF antibody. This invention provides anti-VEGF antibodies formulated as high concentration, aqueous pharmaceutical compositions, suitable for injection, preferably an intravitreal injection. The aqueous pharmaceutical compositions are designed to deliver a high concentration of the antibody active ingredient to a patient while minimizing antibody aggregation and sub-visible particulate matter. The composition includes an antibody with a concentration of at least 50 mg/ml, along with a sugar, a buffering agent, and a surfactant.

Career Highlights

Alok Kulshreshtha is currently associated with Novartis AG, where he continues to innovate in the pharmaceutical sector. His work is pivotal in advancing treatment options for patients requiring high-concentration antibody therapies.

Collaborations

Kulshreshtha has collaborated with notable colleagues such as Huixiang Zhang and Charles Boring, contributing to the advancement of pharmaceutical research and development.

Conclusion

Alok Kulshreshtha's contributions to the field of pharmaceutical formulations exemplify the impact of innovative thinking in healthcare. His patents reflect a commitment to improving patient outcomes through advanced therapeutic solutions.